NuvaRing Lawsuit News from Carey Danis & Lowe NuvaRing Law Firm: Seven Cases Removed from NuvaRing Multicounty Litigation in New Jersey
Carey Danis & Lowe, a NuvaRing law firm representing individuals who have been injured by the contraceptive device, is currently following the NuvaRing multicounty litigation (MCL) taking place in New Jersey. In mid-April a Superior Court Judge in Bergen County New Jersey dismissed seven cases from the Nuvaring MCL. According to the summary judgment order, the seven cases were dismissed from the MCL on the grounds that the plaintiffs in each NuvaRing lawsuit did not provide sufficient evidence connecting their injuries to the use of the NuvaRing contraceptive device. Continue Reading
Carey Danis & Lowe Pradaxa Lawyers Currently Following Pradaxa MDL 2385
Carey Danis & Lowe Pradaxa lawyers are currently following the Pradaxa multi-district litigation (MDL) in Illinois. The Pradaxa MDL is In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation MDL no. 2385. The Pradaxa MDL is being heard in the U.S. District Court for the Southern District of Illinois, and is presided over by Chief Judge David R. Herndon. According to Carey Danis & Lowe Pradaxa lawyers, the Pradaxa MDL 2385 continues to move forward with pre-trial proceedings. As documented in minutes from the latest Pradaxa MDL status conference, the Continue Reading
Mirena IUD Lawyers at Carey Danis & Lowe Applaud Federal Mirena IUD Lawsuits Consolidation into MDL
A Judicial Panel on Multidistrict Litigation (JPML) recently ruled that all federal Mirena IUD lawsuits be consolidated into the U.S. District Court for the Southern District of New York. The JPML ordered that Judge Cathy Seibel hear the Mirena MDL proceedings, according to a HarrisMartin Publishing article. Plaintiffs who have cases in the Mirena IUD MDL No. 2434 filed their lawsuits against Bayer citing serious defects with the intrauterine contraceptive device. According to the plaintiffs, Mirena IUD side effects include the device becoming embedded in the uterus, and in Continue Reading
Discussions Underway in Forming Mirena MDL: Bayer Opposes Consolidating into Mirena MDL
Submit Your Claim A U.S. Judicial Panel on Multi-district Litigation (JPML) met on March 21 in San Diego, California to discuss the consolidation of Mirena IUD lawsuits into a multi-district litigation (MDL). Bayer, the manufacturer of the Mirena intrauterine device (IUD), has expressed a strong opposition against consolidation of lawsuits into an MDL. The German pharmaceutical company opposes the formation of a Mirena MDL, which the Judicial Panel is calling In re: Mirena IUD Products Liablity Litigation, MDL No. 2434, because Bayer believes that a Mirena MDL would stall Continue Reading
Yaz Gallbladder Lawsuit Update: Bayer Settles Gallbladder Injury Yaz and Yasmin Lawsuits for $24 Million
Submit Your Claim A settlement agreement has been reached between Bayer and plaintiffs who filed a Yaz and Yasmin lawsuit specifically citing gallbladder complications. The settlement agreement between the plaintiffs and Bayer, the German pharmaceutical company responsible for the development and marketing of Yaz and Yasmin, was reached on March 15. The plaintiffs’ Yaz gallbladder lawsuits against Bayer were filed in courts across the U.S., including a Yaz and Yasmin multi-district litigation (MDL) in the U.S. District Court for the Southern District of Illinois. The Yaz and Yasmin MDL Continue Reading
Bayer Allocates $1.5 Billion as a Yaz and Yasmin Legal Fund: Settlement Agreements Reached in Yaz and Yasmin Lawsuits
Submit Your Claim According to a Reuters report published on March 4, Bayer allocated $1.5 billion last year as a legal fund for Yaz and Yasmin lawsuits. In anticipation of future settlements of Yaz and Yasmin lawsuits, Bayer has set these funds aside, as it faces thousands more lawsuits. Bayer recently reached a settlement agreement of $1 billion in 4,800 lawsuits filed against them in the U.S. These nearly 5,000 lawsuits were filed against the German pharmaceutical company because, as the plaintiffs claim, ingestion of the contraceptives Yaz and Continue Reading
Pradaxa MDL News: Court Convened for Status Conference in Early February
Submit Your Claim The Pradaxa multi-district litigation (MDL) met in early February for a status conference to discuss recent progress made in the discovery and deposition processes. According to Seth A. Katz, one of the lawyers representing the plaintiffs in the Pradaxa MDL, Boehringer Ingelheim Pharmaceuticals Inc. has not been meeting production deadlines. According to the Pradaxa MDL status conference minutes, the plaintiffs asked for certain documents to be produced by Boehringer Ingelheim, the pharmaceutical company that develops and manufactures Pradaxa, an anticoagulant medicine prescribed to patients with non-valvular Continue Reading
NuvaRing Lawsuit Update: Carey Danis & Lowe Issues Update on NuvaRing Lawsuits and NuvaRing MDL
Submit Your Claim NuvaRing lawsuits continue to be filed across the country with 55 new cases being filed in a St. Clair County Circuit Court in Illinois. According to The Madison Record, 55 individuals have filed a lawsuit against the manufacturer of the NuvaRing, Merck & Co., Inc., alleging that the contraceptive device manufacturer failed to warn healthcare providers and the public about the serious health risks associated with use of the medical device. In addition, these 55 plaintiffs in the Illinois NuvaRing lawsuit state that Merck pursued its Continue Reading
Update on Ethicon MDL in U.S. District Court: Over 3000 Plaintiffs Vaginal Mesh Lawsuits Consolidated into MDL
Submit Your Claim Approximately 3397 cases have been consolidated into the Ethicon multi-district litigation (MDL) being heard in the U.S. District Court for the Southern District of West Virginia. The Ethicon MDL is being presided over by U.S. District Judge Joseph R. Goodwin. In the last pre-trial court order issued by Judge Goodwin, a minor update was given pertaining to the format of the Plaintiff Profile Form, which are documents that release a plaintiff’s medical records for examination. The next Status Conference in the Ethicon MDL will be held Continue Reading
Actos MDL No. 2299 Convened for Status Conference in U.S. District Court in Louisiana
Submit Your Claim Parties involved in the Actos multi-district litigation (MDL) in the U.S. District Court for the Western District of Louisiana met for a Status Conference on January 24, 2013. The MDL is known as in re: Actos (Pioglitazone Products Liability Litigation) MDL No. 11-md-2299, and is being presided over by U.S. District Judge Rebecca F. Doherty. During the most recent Actos MDL Status Conference, the court reviewed recent Actos filings in federal and state courts as well as any new developments since the Actos MDL’s last Status Continue Reading
